Breaking ground with a novel first line dry eye therapy
Based on the IntelliGel platform which delivers moisturizing water and protection for the eye, RP501 is Redwood Pharma’s developmental hydrogel therapy for first line treatment of dry eye disease. IntelliGel is a proprietary novel supramolecular thermogel platform that is currently formulated in dermatological products sold in the US and China. Transparent, non-allergenic, and reversible, IntelliGel is based on poloxamers and other unique polymers that allow for formulations with relatively high water content. Behaving like water at room temperature, it forms a viscous gel when applied